Attain Success Clinical Trial
Launched by MEDTRONIC CARDIAC RHYTHM AND HEART FAILURE · Oct 6, 2009
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject is at least 18 years of age or older
- • Subject will be implanted with Medtronic cardiac resynchronization therapy (CRT) device and Medtronic left heart lead utilizing (or attempting to utilize) Attain Family of delivery catheters. The implant procedure may include upgrades to CRT from implantable pulse generator (IPG) or implantable cardioverter-defibrillator (ICD).
- Exclusion Criteria:
- • Subject is enrolled in a concurrent study with the exception of a study approved by the Medtronic Clinical Trial Leader prior to enrollment
- • Subject has existing CRT system implanted or was previously implanted with a CRT system.
About Medtronic Cardiac Rhythm And Heart Failure
Medtronic Cardiac Rhythm and Heart Failure is a leading division of Medtronic, dedicated to advancing innovative therapies for patients with cardiac rhythm disorders and heart failure. With a commitment to improving patient outcomes, this division focuses on developing cutting-edge medical devices and solutions that enhance the management of arrhythmias and heart failure. Leveraging extensive research and clinical expertise, Medtronic Cardiac Rhythm and Heart Failure aims to transform patient care through evidence-based approaches and a robust pipeline of groundbreaking technologies. Their work not only addresses immediate clinical challenges but also contributes to the long-term health and well-being of individuals with complex cardiac conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Indianapolis, Indiana, United States
Tampa, Florida, United States
Chicago, Illinois, United States
Boston, Massachusetts, United States
St. Louis, Missouri, United States
Cleveland, Ohio, United States
Columbus, Ohio, United States
Nashville, Tennessee, United States
Houston, Texas, United States
Krakow, , Poland
Santa Rosa, California, United States
Baltimore, Maryland, United States
Minneapolis, Minnesota, United States
Dallas, Texas, United States
New Dehli, , India
Taipei, , Taiwan
San Diego, California, United States
Washington, District Of Columbia, United States
Orlando, Florida, United States
Lexington, Kentucky, United States
Little Rock, Arkansas, United States
Austin, Texas, United States
Salt Lake City, Utah, United States
Kettering, Ohio, United States
Decatur, Illinois, United States
Omaha, Nebraska, United States
Fort Worth, Texas, United States
San Juan, , Puerto Rico
Riverside, California, United States
Green Bay, Wisconsin, United States
Bydgoszcz, , Poland
Spokane, Washington, United States
Modesto, California, United States
Wormleysburg, Pennsylvania, United States
Amarillo, Texas, United States
Paris, , France
Overland Park, Kansas, United States
Nice, , France
Marietta, Georgia, United States
Bangkok, , Thailand
Royal Oak, Michigan, United States
New Delhi, , India
Macon, Georgia, United States
Ontario, , Canada
Bucharest, , Romania
San Jose, California, United States
Asheville, North Carolina, United States
Bordeaux, , France
Englewood, New Jersey, United States
Amiens, , France
Taichung, , Taiwan
Creteil, , France
Germantown, Tennessee, United States
Longview, Texas, United States
Kuala Lumpur, , Malaysia
Houma, Louisiana, United States
Sha Tin, , Hong Kong
Naples, Florida, United States
Orleans, , France
Rajasthan, , India
Danbury, Connecticut, United States
Erie, Pennsylvania, United States
Clermont Ferrand, , France
Poitiers, , France
Bellingham, Washington, United States
Ypsilanti, Michigan, United States
Abington, Pennsylvania, United States
Fargo, North Dakota, United States
Concord, New Hampshire, United States
Panama City, Florida, United States
Newburgh, Indiana, United States
Bethlehem, Pennsylvania, United States
Brasov, , Romania
Huntington, New York, United States
Takoma Park, Maryland, United States
The Woodlands, Texas, United States
Bayonne, , France
Athens, Georgia, United States
Delray Beach, Florida, United States
Bowling Green, Kentucky, United States
Murray, Utah, United States
Florence, South Carolina, United States
Brownsville, Texas, United States
Downey, California, United States
Harrisburg, Pennsylvania, United States
Lake Mary, Florida, United States
Villingen, , Germany
Lahore, , Pakistan
Jiangsu, , China
Montfermeil, , France
Redding, California, United States
Muskegon, Michigan, United States
Haryana, , India
St. Augustine, Florida, United States
Saint Clair Shore, Michigan, United States
Washinton, Missouri, United States
Knoxsville, Tennessee, United States
Frederickburg, Virginia, United States
Sichuan, , China
Xinjian, , China
Anglouleme, , France
Metz Tessy, , France
Vizag, , India
Tal Qroqq, , Malta
Zabreze, , Poland
Novena, , Singapore
Patients applied
Trial Officials
John D Hummel, MD
Principal Investigator
Davis Heart & Lung Research Institute, The Ohio State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials